Patent Assignment
Reel/Frame 053455/0012
Assignment of Assignor's Interest
Recorded: 2020-08-11
Pages: 4
Assignor
SYNGENE INTERNATIONAL LIMITED
Executed: 2020-08-01
Assignee
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(2)
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitord and Uses Thereof
PCT:
PCT/US2020/040737 ↗
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 11, 2020
From: BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WARNER, STEVEN L.; WHATCOTT, CLIFFORD J.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053453/0429 →
Assignment of Assignor's Interest
Aug 11, 2020
From: SEENISAMY, JEYAPRAKASHNARAYANAN
To: SYNGENE INTERNATIONAL LIMITED
Reel/Frame 053453/0487 →
Change of Name
Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →